Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock

This feasibility study evaluates a new mechanical heart support device called the Magenta Elevate in patients experiencing cardiogenic shock — a life-threatening condition where the heart suddenly cannot pump enough blood to meet the body's needs. **You may be eligible if...** - You are experiencing cardiogenic shock that started within the past 24 hours - Your heart's pumping function (left ventricular ejection fraction) is between 15% and 45% - You have no more than mild right-sided heart failure - You or your representative is able to sign informed consent **You may NOT be eligible if...** - Your shock is caused by something other than heart failure (such as infection, low blood volume, blood clot, or allergic reaction) - Your blood oxygen level is very low and cannot be improved with supplemental oxygen or a breathing tube - You have severe right heart failure - You have a dangerous heart rhythm (sustained VT) at the time of enrollment Talk to your doctor to see if this trial is right for you.